I work as part of the MS research team carrying out commercial and academic studies. I am also involved in the biology of MS and novel imaging techniques.
et al., 2017, Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions, Neuroimage-clinical, Vol:13, ISSN:2213-1582, Pages:9-15
et al., 2017, Programmed death 1 is highly expressed on CD8+CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to EBV., Immunology, ISSN:0019-2805
et al., 2017, Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial, Lancet Neurology, Vol:16, ISSN:1474-4422, Pages:591-600
et al., 2017, [(11)C]PBR28 or [(18)F]PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis., J Nucl Med, ISSN:0161-5505, Pages:jnumed.116.187161-jnumed.116.187161
et al., 2017, Natalizumab granule cell neuronopathy: FDG-PET in diagnosis and immune reconstitution with G-CSF, Neurology, Neuroimmunology and Neuroinflammation, Vol:4, ISSN:2332-7812